BLC
PGEN icon

Brown, Lisle/Cummings’s Precigen PGEN Stock Holding History

Brown, Lisle/Cummings’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,500
Closed -$1.42K – 655
2024
Q3 		$1.42K Sell
1,500
-750
-33% -$946 ﹤0.01% 585
2024
Q2 		$3.56K Buy
+2,250
New +$3.27K ﹤0.01% 533

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown, Lisle/Cummings's PGEN Position: Q4 2024 in Review

Brown, Lisle/Cummings sold out of Precigen (PGEN) in Q4 2024, closing a stake of 1,500 shares — an estimated $1.42K sold.

Brown, Lisle/Cummings first reported a position in PGEN in Q2 2024 and held it in 2 quarters. The position peaked at $3.56K in Q2 2024. 133 funds tracked by Wall St. Rank hold PGEN as of Q4 2024.

  • Brown, Lisle/Cummings reported no remaining Precigen position as of Q4 2024 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 1,500 Precigen shares in Q4 2024, an estimated $1.42K.
  • Brown, Lisle/Cummings first reported a position in Precigen in Q2 2024 and held it in 2 quarters.
  • Brown, Lisle/Cummings's Precigen position peaked at $3.56K in Q2 2024.
  • 133 funds tracked by Wall St. Rank held Precigen as of Q4 2024.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.